• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国武汉新冠病毒无症状感染者的病毒传播及临床特征

Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China.

作者信息

Tan Fen, Wang Kaige, Liu Jiasheng, Liu Dan, Luo Jianfei, Zhou Rui

机构信息

Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Respiratory Disease Research Institute of Hunan Province, Central South University, Changsha, China.

Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Med (Lausanne). 2020 Aug 18;7:547. doi: 10.3389/fmed.2020.00547. eCollection 2020.

DOI:10.3389/fmed.2020.00547
PMID:33015099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7461982/
Abstract

We report the clinical characteristics, viral shedding duration, and contact tracing for asymptomatic carriers of SARS-CoV-2 in Wuhan, China. The asymptomatic carriers were relatively young (median age: 34.5 years). Chest computed tomography showed no abnormalities. The nasopharyngeal swab was an optimum specimen for RNA testing. The median viral shedding duration was 11.5 days. Notably, 2 months of viral shedding duration were reported in two nurses, which was much longer than previously reported or than usually thought. The transmissibility of SARS-CoV-2 by asymptomatic carriers during the studied period in Wuhan appeared to be weak. Only one patient (1/12) was found to have transmitted the virus to another person. Early asymptomatic carrier detection, isolation, and contact tracing could be useful to mitigate the spread of the disease.

摘要

我们报告了中国武汉新冠病毒无症状感染者的临床特征、病毒 shedding 持续时间及接触者追踪情况。无症状感染者相对年轻(中位年龄:34.5 岁)。胸部计算机断层扫描显示无异常。鼻咽拭子是 RNA 检测的最佳标本。病毒 shedding 持续时间的中位数为 11.5 天。值得注意的是,两名护士报告的病毒 shedding 持续时间为 2 个月,这比之前报道的或通常认为的要长得多。在武汉研究期间,无症状感染者传播新冠病毒的能力似乎较弱。仅发现 1 例患者(1/12)将病毒传播给了另一人。早期发现无症状感染者、隔离及接触者追踪对于减轻疾病传播可能有用。 (注:“shedding”在这里可能是指病毒排出之类的意思,文中未明确给出更准确中文释义)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69f/7461982/994efb1787c4/fmed-07-00547-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69f/7461982/994efb1787c4/fmed-07-00547-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69f/7461982/994efb1787c4/fmed-07-00547-g0001.jpg

相似文献

1
Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China.中国武汉新冠病毒无症状感染者的病毒传播及临床特征
Front Med (Lausanne). 2020 Aug 18;7:547. doi: 10.3389/fmed.2020.00547. eCollection 2020.
2
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.新型冠状病毒肺炎成年住院患者痰液与鼻咽拭子标本中 2019 年冠状病毒脱落持续时间的差异。
Chest. 2020 Nov;158(5):1876-1884. doi: 10.1016/j.chest.2020.06.015. Epub 2020 Jun 20.
3
Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.无症状 SARS-CoV-2 携带者和有症状/症状前 COVID-19 患者的流行病学特征、病毒脱落和抗体血清转换。
J Infect Public Health. 2021 Jul;14(7):845-851. doi: 10.1016/j.jiph.2021.05.003. Epub 2021 May 27.
4
Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.中国武汉一家 COVID-19 治疗医院患者的临床特征和抗体反应。
J Med Virol. 2021 May;93(5):2782-2789. doi: 10.1002/jmv.26617. Epub 2021 Mar 1.
5
Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study.在潜伏期内 COVID-19 无症状快速传播,在武汉以外的一群年龄在 16-23 岁的年轻人中表现出很强的传染性,以及 COVID-19 年轻患者的特点:一项前瞻性接触者追踪研究。
J Infect. 2020 Jun;80(6):e1-e13. doi: 10.1016/j.jinf.2020.03.006. Epub 2020 Apr 10.
6
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.SARS-CoV-2 G614 感染(武汉株)患者新冠病毒载量随症状出现和严重程度的变化轨迹。
JAMA Netw Open. 2022 Jan 4;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.
7
Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China.SARS-CoV-2 无症状感染的医护人员:中国武汉一家大型教学医院的研究。
Int J Infect Dis. 2020 Oct;99:219-225. doi: 10.1016/j.ijid.2020.07.082. Epub 2020 Aug 3.
8
Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.中国南京接触者中 24 例新冠肺炎无症状感染的临床特征。
Sci China Life Sci. 2020 May;63(5):706-711. doi: 10.1007/s11427-020-1661-4. Epub 2020 Mar 4.
9
Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.从有症状、无症状或症状后个体的呼吸道和口腔配对标本中检测 SARS-CoV-2 的病毒 RNA 载量和感染力。
Microbiol Spectr. 2022 Jun 29;10(3):e0226421. doi: 10.1128/spectrum.02264-21. Epub 2022 May 16.
10
Clinical characteristics of patients with confirmed and asymptomatic SARS-CoV-2 infection in China.中国确诊和无症状 SARS-CoV-2 感染患者的临床特征。
PLoS One. 2022 Aug 23;17(8):e0273150. doi: 10.1371/journal.pone.0273150. eCollection 2022.

引用本文的文献

1
Viral shedding of SARS-CoV-2 in body fluids associated with sexual activity: a systematic review and meta-analysis.体液中与性行为相关的 SARS-CoV-2 病毒脱落:系统评价和荟萃分析。
BMJ Open. 2024 Feb 21;14(2):e073084. doi: 10.1136/bmjopen-2023-073084.
2
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.用于对抗SARS-CoV-2的纳米材料:预防、诊断和治疗新冠肺炎的策略。
Front Bioeng Biotechnol. 2022 Nov 25;10:1052436. doi: 10.3389/fbioe.2022.1052436. eCollection 2022.
3
Epidemiological, Radiographical, and Laboratorial Characteristics of Chinese Asymptomatic Cases With COVID-19: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.血浆疗法治愈了一名病毒脱落持续49天的新冠肺炎患者:临床特征、实验室检查、血浆疗法及对公共卫生管理的启示
MedComm (2020). 2020 May 27;1(1):77-80. doi: 10.1002/mco2.2. eCollection 2020 Jun.
2
Clinical Validity of Serum Antibodies to SARS-CoV-2 : A Case-Control Study.血清抗 SARS-CoV-2 抗体的临床有效性:一项病例对照研究。
Ann Intern Med. 2020 Oct 20;173(8):614-622. doi: 10.7326/M20-2889. Epub 2020 Jul 6.
3
High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020.
《COVID-19 无症状中国病例的流行病学、影像学和实验室特征:系统评价和荟萃分析》。
Front Public Health. 2022 Mar 31;10:808471. doi: 10.3389/fpubh.2022.808471. eCollection 2022.
4
Host methylation predicts SARS-CoV-2 infection and clinical outcome.宿主甲基化可预测新冠病毒感染及临床结局。
Commun Med (Lond). 2021;1(1):42. doi: 10.1038/s43856-021-00042-y. Epub 2021 Oct 26.
5
Geo-clusters and socio-demographic profiles at village-level associated with COVID-19 incidence in the metropolitan city of Jakarta: An ecological study.雅加达首都特区与 COVID-19 发病率相关的村落级地理集群和社会人口特征:一项生态学研究。
Transbound Emerg Dis. 2022 Jul;69(4):e362-e373. doi: 10.1111/tbed.14313. Epub 2021 Sep 25.
6
Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis.新冠病毒感染中病毒脱落时间特征:系统评价和荟萃分析。
Front Public Health. 2021 Mar 19;9:652842. doi: 10.3389/fpubh.2021.652842. eCollection 2021.
7
Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review).新型冠状病毒无症状感染者的临床特征与传染性(综述)
Exp Ther Med. 2021 Feb;21(2):115. doi: 10.3892/etm.2020.9547. Epub 2020 Dec 3.
美国加利福尼亚州帕萨迪纳市 9 家长期护理机构中 SARS-CoV-2 无症状感染比例较高,2020 年 4 月。
Emerg Infect Dis. 2020 Oct;26(10):2416-2419. doi: 10.3201/eid2610.202694. Epub 2020 Jul 2.
4
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
5
A study on infectivity of asymptomatic SARS-CoV-2 carriers.无症状 SARS-CoV-2 携带者的传染性研究。
Respir Med. 2020 Aug;169:106026. doi: 10.1016/j.rmed.2020.106026. Epub 2020 May 13.
6
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China.中国武汉无症状与有症状新冠肺炎患者的临床特征比较。
JAMA Netw Open. 2020 May 1;3(5):e2010182. doi: 10.1001/jamanetworkopen.2020.10182.
7
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
8
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.在一家专业护理机构中出现的 SARS-CoV-2 感染前驱期和传播。
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
9
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征:一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
10
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.估算 2020 年日本横滨钻石公主号游轮上的 2019 年冠状病毒病(COVID-19)病例的无症状比例。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180.